Index | Caspase | CARD/DED/BIR | Bcl-2 | DD | TNF/TNFR | Kinases | ILs | Viral | Lipid | Engulf | TF | RING | Toll | Other Apop | Other NFkB | Alphabet |
E3-related proteins
RING proteins and their-related proteins
Subgroup | Protein Name |
|
|
KO | Structure | Locus | 3D | substrates | (other or undefined) binding partners | upstream regulators | memo |
BRCA1 & BRCT |
BRCA1(human, mouse, rat) |
|
L | RING/?/BRCTx2 | L | BRCA1, H2A, H2AX, H2B, H3, H4, B23 | UBC4, UbcH5a, UBCH5c, ATF1, BAP1, BRAP, BARD1, CBP, CtIP, Elk-1, KPNA1, Lyn, p53, RAD50, 53BP1, IFI16, BRIP1, ZBRK1 | CREB,c-Myc, E2F6, GABPs, Id4, BRCA1, FANCD2, nicotine, irrrad, methylation | bm, gene targets | ||
BARD1(human) |
|
RING/ANKx3/BRCTx2 | 2q34-q35 | w/BRCA1 | BRCA1, p53 | stress | bm, calpain | ||||
53BP1, TP53BP1 (human, mouse, Xenopus) |
|
?/BRCTx2 | 15q15-q21 | w/p53 | p53, BRCA1 | ATM, DNA damage, | |||||
MDC1, NFBD1 (human) |
|
FHA/BRCT | 6pter-p21.31 | CHK2 | MeDNA | bm, preB |
|||||
FLJ12847 (human, Dm) | BRCTx2 | 8p23.1 | Rho |
NK, B |
|||||||
TOPBP1(human), MUS101(Dm) | BRCTx7 | 3q22.2 | TopII, E2F1 | bm, B, T, NK |
|||||||
ECT2
(human) |
induce |
BRCTx2/RhoGEF/PH |
3q26.1-q26.2 |
||||||||
F37D6.1(Ce) | BRCTx5 | ||||||||||
At1g04020(At) | RING/PHD/BRCTx2 | ||||||||||
CBL |
CBL(human, mouse, chicken, Dm, Ce) |
|
L | SH2(Y-P BD)/RING/ZF/UBA | 11q23.3 | w/Ubch7 | PDGFRa,
ErbB1,
Syk,
Lck,
Lyn,
Fyn,
RON,
c-Kit,
TCRzeta,
PI3Kp85,
Hck,
c-Met,
EGFR,
Flk1,
EphA2,
Notch1,
Vav,
p75NTR |
Ubch7, APC, SPRY2, CIN85, CMS | cisplatin, UVA, HECTs | ||
CBL-B(human) | L | CBL-N/SH2/RING | 3q13.11 | PI3Kp85, EGFR, Kit, PDGFR, C3G | CIN85 | FKHRL1 | CD28 | ||||
CBL-C, CBL3 (human) | 1 | CBL-N/RING | 19q13.2 | EGFR | AIP4, WWP1 | epithelium |
|||||
IAPs | see BIR proteins | ||||||||||
MDM2 |
Mdm2 (human(hdm2), mouse, Xenopus) |
|
|
MDM2/ZF/RING | 12q14.3-q15 | L | p53, p73, AR, mdm2, mdmX, Numb, Tip60 | p19ARF, mdm4, p75a, TAFII250, HDAC1 | p53, BRCA1, c-Myc, O stress, NO, irrad., bFGF, IGF-I, IGF-II, Lm, UV, SUMO-1, Ubc9; p38, Akt, PLD, HIPK1, VSV, estrogen | ||
Mdm4/mdmX(human, mouse) |
|
|
1q32 | p53, mdmX | N-Myc, ARNT2 | ||||||
TRAF | TRAFs, TRAF-related proteins
(including TRIM37), see "other
NF-kB regulators" |
||||||||||
TRIP | see "other
NF-kB regulators" |
||||||||||
MEKK1 | see kinases | ||||||||||
Siah-1 | Siah-1(human), Sina (Dm) |
|
L | RING/ZFx2/TRAF-C-like | 16q12 | 1 | rpvaxVxPxxr, b-catenin, Kid, DCC, BAG1, Myb, N-CoR, synphilin-1, CtIP, Numb, Tramtrack | BAG-1, mGluR,Ubc9, UbcH5, PHYL, Vav, a-tublin, SIP, polycystin-1, PEG10, Phyllopod, Ebi | p53, insulin, disabled1, LPS | Ras-dep. | |
Siah-2(human) |
|
L | RING/TRAF-C-like | 3q25 | TRAF2 | Vav, | |||||
Multi-RING | parkin, Park2 (human, mouse) |
|
UBQ/RING/(IBR)/RING/(IBR) | 6q25.2-q27 | L | CDCrel-1, a-synuclein, synphilin-1, aminoacyl-tRNA synthetase | UbcH7,
UbcH8,
CHIP, Hsp70, Rpn10 |
FLRF | casp, leprosy suscept. | ||
ariadne, UBCH7BP, HHARI, ARIH1, UIP77 (human, Dm) | Dm | ?/RING/(IBR)/RING/(IBR)/? | 15q24 | 4EHP | UbcH7, UbcH8, UbcM4 | ||||||
TRIAD1, ARIH2, ariadne-2, UIP48 (human, mouse) | ?/RING/(IBR)/RING/(IBR)/RING/(IBR)/? | 3p21.2-p21.3 | UbcM4 | hypoxia, Blimp1 | |||||||
ARA54, HFB30, RNF14 (human) | RWD/RING/(IBR)/RING/(IBR) | 5q23.3-q31.1 | AR | ||||||||
KIAA0161 (human) | RING/(IBR)/RING/(IBR)/RING | 2p25.3 | |||||||||
RNF144 (human, mouse) | RING/(IBR)/RING | 2p25.2 | |||||||||
dorfin, RNF19 (human) | inhibit? |
RING/(IBR)/RING/(IBR)/TMx2? | 8q22 | synphilin-1 | Sp1 | AdV,
Ret |
|||||
C20orf18 (human) | UBQ/ZF/RING | 20p13 | |||||||||
XAP3, UIP28, HOIL-1, RBCK1, C20orf18 (human) | UBQ/ZF/RING/(IBR)/RING/(IBR) | 20p13 | ox.IRP2 | UbcM4, HBV-X, PKCbI | |||||||
TRIAD3, UIP83, ZIN (human) | RING/(IBR)/RING/(IBR) | 7p22.2 | TLRs |
RIP | |||||||
ZIBRA, RNF31 (human) | RING/(IBR)/RING | 14q11.2 | |||||||||
p53RFP, IBRDC2 (human, mouse, zebrafish) | RING/(IBR)/RING | 6p22.3 | p53 | ||||||||
PDZ |
LNX(human, mouse) | RING/PDZx4 | 4q11 | Numb | |||||||
LNX2, MGC46315 (human) | RING/PDZx4 | 13q12.13 | |||||||||
PDZRN3 (human) |
RING/PDZx2/cc | 3p14.1 |
|||||||||
LNX4, PDZRN4 (human) |
RING/PDZx2/cc |
12q12 |
|||||||||
TRIM | Ro52, SSA1(human) | RING/ZF(B)/cc/PRY/SPRY | 11p15.5 | Ro52 | RNA, Ro60, UnpEL | TNFa, IFNa/b, IFNg, | B, T | ||||
RoRet, TRIM38, RNF15 (human) | induce | RING/ZF(B)/cc/PRY/SPRY | 6p21.3 | hemato. |
|||||||
RFP, TRIM27 (human) |
|
RING/ZF(B)/cc/PRY/SPRY | 6p22 | DNA | |||||||
TRIM4 (human) | RING/ZF(B)/cc/PRY/SPRY | 7q22-q31.1 | |||||||||
TRIM5 (human) | RING/ZF(B)/cc/PRY/SPRY | 11p15 | TRIM5 | ||||||||
TRIM15 (human) | RING/ZF(B)/cc/PRY/SPRY | 6p21 | |||||||||
TRIM11, BIA1 (human) | RING/ZF(B)/cc/PRY/SPRY | 1q42.13 | Humanin | ||||||||
TRIM17, RNF16, TERF (human) | RING/ZF(B)/cc/PRY/SPRY | 1q42 | |||||||||
TRIM41 (human) | RING/ZF(B)/cc/PRY/SPRY | 5q35.3 | Brn3b | ||||||||
TRIM23 (human) | RING/ZF(B)/cc/PRY/SPRY | 6p21.3 | |||||||||
TRIM26, ZNF173 (human) | RING/ZF(B)/cc/PRY/SPRY | 6p21.3 | MVA | ||||||||
TRIM35, MAIR (human) | induce | RING/ZF(B)/cc/PRY/SPRY | 8p21.1 | M-CSF | |||||||
Efp, ZNF147 (human) | 1 | RING/ZF(B)/cc/PRY/SPRY | 17q23.1 | 14-3-3sigma | estrogen, IFNa/b,
LPS,
HOX11 |
||||||
SS-56, Ro/SSA SS-56, FLJ10369, RNF137 (human) | RING/ZF(B)/cc/PRY/SPRY | 11pter-p15.5 | |||||||||
TRIM22, STAF50 (human) | RING/ZF(B)/cc/PRY/SPRY | 11p15 | IFNa/b, HCV | hemato. |
|||||||
TRIM14 (human) | /ZF(B)/cc/PRY/SPRY | 9q22.33 | HCV, Lm | hemato. |
|||||||
FLJ10759 (human) | RING/ZF(B)/cc/PRY/SPRY | 1p35.1 | |||||||||
TRIM2 (human) | RING/ZF(B)/cc(BBC)/IG/NHLx6 | 4q31.23 | brain |
||||||||
TRIM34, BERP, RNF21 (human) | RING/ZF(B)/cc(BBC)/IG/NHLx6 | 11p15.5 | IFN | ||||||||
TRIM32 (human) | RING/ZF(B)/cc(BBC)/IG/NHLx6 | 9q32-9q34.11 | tat | DAC/TSA, A2aR | |||||||
TRIM3, BERP, HAC1, RNF22(human) | RING/ZF(B)/cc(BBC)/IG/NHLx6 | 11p15.5 | |||||||||
Midline 1, OSX, MID1, FXY, TRIM18 (human) | RING/ZF(B)x2/cc(BBC)/FN3/PRY | Xp22 | |||||||||
Rbcc728, TRIM36 (human) | RING/ZF(B)/cc(BBC)/FN3/PRY | 5p14.2-q22.3 | |||||||||
TRIM46, FLJ23229 (human) | RING/ZF(B)/cc(BBC)/FN3 | 1q21.2 | |||||||||
TRIM9 (human) | RING/ZF(B)x2/cc(BBC)/FN3/PRY/SPRY | 14q21.3 | HNF4a | brain |
|||||||
TIF1, TRIM24 (human), bonus, bon (Dm) | RING/ZF(B)/cc(BBC)/PHD/BROMO | 7q32-q34 | ER | estrogen | |||||||
KAP1, TIF1beta, TRIM28 (human, mouse) | RING/ZF(B)/cc(BBC)/PHD/BROMO | 19q13.4 | ZFPs;( KOX1, KRAZ1, MZF13, 6D, MZF22, HZF4,KRAZ2,MTZ1, HP1), GR, NF-IL6, MM1, SETDB1 | ||||||||
TIF1gamma, TRIM33, PTC7, RFG7, TF1G, TIF1G, Ectodermin/Ecto (human) | RING/ZF(B)/cc/PHD/BROMO | 1p13.1 | SMAD4 |
||||||||
RFPL1 (human) | RING/PRY/SPRY | 22q12.3 | |||||||||
RFPL2 (human) | RING/PRY/SPRY | 22q12.3 | |||||||||
RFPL3 (human) | RING/PRY/SPRY | 22q12.3 | |||||||||
HZFw1 (human) | RING/PRY/SPRY | 6p21.3 | |||||||||
RNF18 (human) | RING/ZF(B)/SPRY | 11p11.12-q12 | |||||||||
ASH2L, Ash2 (human, Dm) | dm | RING(PHD)/SPRY | 8p11.2 | CREB | |||||||
TRIM8, RNF27 (human) | RING/ZF(B)/cc | 10q24.3 | SOCS1 | APCs, NK |
|||||||
TRIM31(human) | RING/ZF(B)/cc | 6p21.3 | |||||||||
LEU5, RFP2(human) | induce |
RING/ZF(B)/cc | 13q14.3 | RA | testis, oocyte |
||||||
Nrdp1, FLRF, SBBI03 (human) | RING/ZF(B)/cc/ErbB3AD | 12q12 | ErbB3, ErbB4, BRUCE | UBP8 |
|||||||
MuRF1, RNF28, SMRZ (human) | 1 | RING/ZF(B)/cc(BBC) | 1p34-p33 | titin, SMT3b | GMEB-1 | heart, sk. muscle |
|||||
MuRF-2, RNF29 (human) | RING/ZF(B)/cc(BBC) | 8q13.1 | |||||||||
MuRF-3, RNF30 (human) | RING/ZF(B)/cc(BBC) | 2p23.2 | |||||||||
TRIM52, RNF102, MGC16175 (human) | RING/ZF(B) | 5q35.3 | hemato. |
||||||||
TRIM48, RNF101, MGC4827 (human) | RING/ZF(B) | 11q12.1 | |||||||||
Other ZF | PML, TRIM19 (human, mouse, rat) |
|
L | RING/ZFx2 | 15q22 | 1 | eIF4E, DAXX, p53, Rb, HDAC | p53, BCR, TNFa, IFNa, IFNb, IFNg, Ld, SUMO,b-catenin, sentrins | B, PML/RAR by t(15;17) | ||
ZNF313 (human) | RING/ZF x2 | 20q11.21-q11.23 | |||||||||
RNF125, FLJ20456, TRAC1 (human) | RING/ZF | 18q11.2 | RNF125 |
B, T, NK |
|||||||
STRIN (human) | RINGx2 | 18q11.2 | hemato. |
||||||||
NF-X1, NFX1 (human) | RING/ZFx9/R3H | 9p13.3 | NF-X1 | repressor of MHCII | |||||||
HSPC070, RNF62, makonin 2, MKRN2 (human) | ZFx3/RING/ZF | 3p25 | |||||||||
makorin, ZFP127, MKRN1 (human) | ZFx2/RING/ZF | 15q11-q13 | hTERT |
||||||||
cc | RAG1 (human) | L | ?/cc/RING/? | 11p13 | 1 | S-peptide, RAG1 | CD40 | thy |
|||
RAG2 (human) | L | ?/PHD(RING)/? | 11p13 | CD40, Subst.P | |||||||
RBP95, Staring, RNF40 (human) | cc x6/RING | 16p11.2-p11.1 | Syntaxin 1 | Rb, UbcH8 | |||||||
RNF20 (human) | cc x6/RING | 9q22 | |||||||||
RNF123, FLJ12565 (human) | ?/cc/RING | 3p24.3 | |||||||||
DZIP3, hRUL138, KIAA0675 (human) | ccx2/RING | 3p13-q13.2 | HBV RNA | ||||||||
MAT1, MNAT1 (human, mouse, rat, Xl) | 1 | RING/cc | 14q23 | cyclin H, CDK7, TFIIH, Oct1, Oct2, Oct3, MTA1 | |||||||
FLJ35794 (human) | RING/cc | 3q29 | |||||||||
RCC1 | MYCBP2, KIAA0916 (human) | RCC1/ZF(B)/RING | 13q22 | Myc |
B, T, NK, brain |
||||||
TUDOR | PHF1 (human) | TUDOR/RING(PHD)x2 | 6p21.3 | B, T, NK, oocyte |
|||||||
Rad18 | Rad18 (human) | RING/ZnF(Rad18)/SAP | 3p25-p24 | PCNA | Rad6 | ||||||
KIAA1972 |
KIAA1972 (human) |
?/SPRY/RING |
16q13 |
Subgroup | Protein Name | Apoptosis | NF-kB | KO | Strucuture | Locus | 3D | Substrate | (other or undefined) binding partners | upstream regulators | Memo |
FHA | Chfr (human, mouse) | 1 |
FHA/cc/RING | 12q24.33 | 1 | (P-Thr); Chfr, Plk1 | Aurora
A |
methylation | T, NK, myeloid |
||
RNF8 (human, mouse, rat, Xl, zebrafish) | FHA/cc/RING | 6p21.3 | ActA, RXRa | oocyte |
|||||||
MIR | MIR, MYLIP (human) | FERM/RING | 6p23-p22.3 | CD86 | myosin L | B, prostate |
|||||
Hakai | Hakai (human) | RING/PHD | 7q22.2 | E-cadherin | endothelial, endocytosis | ||||||
DRP | DRP1, DMDL, Uterophin (human) | CHx2/SPECx>19/WW/ZF(zz)/cc | 6q24 | ||||||||
RRM | CNOT4 (human, Sc) | RING/cc/RRM/ZF-CCCH | 7q22-qter | ||||||||
BRAP (human) | RRM/RING/ZF/cc | 12q24 | NLS | ||||||||
FYVE | RBQ1, RBBP6 (human) | FYVE/RING/cc | 16p12-p11.2 | Rb | hemato |
||||||
FRING, Sakura, CARP2 (human, mouse) | FYVE/RING | 17q11.2 | FRING | ||||||||
RIFF, RNF34, Momo, CARP1 (human, mouse, rat) | inhibit |
FYVE/RING | 12q24.31 | RIFF casp8, casp10 |
|||||||
IQ | RNF32 (human) | RING/IQ/RING | 7q35-q36 | ||||||||
C-WD40 | COP1 (human) | inhibit |
RING/cc/WD40x6 | 1q24.1 | c-Jun,
p53 |
hemato. |
|||||
RFWD1, TRAF7 (human) |
|
activate | RING x2/cc/WD40 x7 | 16p13.11 | RFWD1 | MEKK3, RFWD1 | |||||
DKFZp434F054 (human) | RING/WD40x6 | 16p13.3 | preB |
||||||||
TPR | RNF127, FLJ22612 (human) | TPRx2/RING/LON | Xq24 | ||||||||
TTC3 (human) | TRPx4/cc/RING | 21q22.2 | brain |
||||||||
rapsyn, RAPSN (human) | 1 | TRPx6/RING | 11p11.2-p11.1 | ||||||||
N-WD40R | VPS11 (human) | WD40x4/CLH(LH2)/cc/RING | 11q23 | syntaxin 7 | |||||||
UBQ | URF2, NIRF, ICBP90, NP97 (human) | UBQ/PHD(RING)/SRA | 9p24.1-p23 | PCNP | |||||||
SAND | AIRE (human, mouse) | 1 | Sp100/SAND/PHD(RING)x2 | 21q22.3 | LT | targets |
|||||
Tal |
Tal, LRSAM1 (human) | LRRx4/ERM/CC/SAM/RING |
9q34.13 |
TSG101 |
|||||||
Memb. | PEX10, peroxin 10 (human, mosue, rat) | ?/TM/RING | 1p36.11-1p36.33 | PEX5, PEX10 | |||||||
RNF13, RZF (human) | PA/TM/RING | 3q24 | IL5,
IFNa,
insulin,
IGF-II,
ALA |
||||||||
DKFZP566H073 (human) | PA/TM/RING | 17p13.3 | |||||||||
GREUL1, GRAIL, FLJ23516 (human, mouse) | PA/TM/RING | Xq22.2 | Stat4 | ||||||||
RNF133, LOC168433 (human) | PA/TM/RING | 7q22.1 | |||||||||
RNF149, LOC284996 (human) | PA/TM/RING | 2q12.1 | |||||||||
IBRDC1 (human) | IBRx2/TM | 6q22.33 | |||||||||
BAR, BFAR, RNF47 (human) |
|
RING/TM/SAM/TMx2 | 16p13.13-16p12.3 | Bcl-2, Bcl-xL, Caspase-8, Caspase-9 | oocyte |
||||||
ZNF179 (human) | RING/GBP/TMx2 | 17p11.2 | brain |
||||||||
IBRDC3, FLJ90005 (human) | IBRx2/TMx2 | 1p34.3 | PBL |
||||||||
ZFP103, kf-1(human) | ?/TMx3/RING | 2p11.2 | KF-1 | ||||||||
RNF26 (human) | TMx3/RING | 11q23 | |||||||||
ZFP103 (human) | TMx3/RING | 2p11.2 | |||||||||
TRC8, RNF139 (human) | d | TMx13/RING | 8q24 | TRC8, JAB1, VHL | |||||||
FLJ12875 (human, At, Dm) | induce |
?/TM/RING | 1p36.13 | ||||||||
FLJ20225 (human) | RING/TMx2 | 1p36.13 | |||||||||
KIAA1399
(human) |
RING/TMx2 | 2q35 |
RANTES |
||||||||
G1RP, goliath, RNF130 (human) | TM/RING/(TM) | 5q35 | IL3 | APCs |
|||||||
AMFR (human) | TMx5/RING/CUE | 16q21 | AMF | ||||||||
LOC285533 (human) | TMx5/RING | 4q31.3 | brain |
||||||||
HRD1, Synoviolin (human, mouse) |
|
1 | TMx5/RING | 11q12 | ER proteins | ER stress, IRE1, ATF6, c-Myb | |||||
FLJ31951 (human) | TMx12/RING | 5q34 | |||||||||
Np95 | Np95, ICBP90, UHRF1, RNF106 (human) |
|
1 | Ub/RING/SRA/RING | 19p13.3 | H3 | E1A | Thy, bm, oocyte |
|||
neuralized | neuralized/ neu, NEURL, RNF67 (human, Xl, Dm) | NEUZ x2/RING | 10q25.1 | Delta | Notch | ||||||
helicase | HIP116, HLTF, SNF2L3, SMARCA3 (human) | helicase/RING/helicase C | 3q25.1-q26.1 | Sp1, Sp3 | |||||||
ATRX (human) | RING/cc/DEXD/helicase C | Xq13.1-q21.1 | Daxx | hemato. |
|||||||
KH | Tino, RKHD1 (human partial, rat) | KHx2/RING | 19p13.3 | Bcl-2 mRNA | |||||||
LOC51320 (human) | KHx2/RING | 18q21.1 | hemato. |
||||||||
Mib |
DIP1, Mib, Mib1 (human, zebrafish, Dm) |
|
HERC2/ZnF/HERC2/Mibx2/Ank/RINGx2/cc/RING | 18q11.2 | Delta, DIP1, DAPK | ||||||
MIB2 (human) |
1p36.33 |
Delta |
|||||||||
novelzin | skeletrophin, novelzin,
LOC142678 (human) |
induce |
ZnF/Ankx9/RINGx2 |
1p36.32 |
|||||||
SH3 | SH3RF2, FLJ23654, RNF158 (human) | RING/SH3x3 | 5q31.3-q32 | ||||||||
POSH, RNF142, SH3RF1, SH3MD2 (human) | RING/SH3x6 | 4q32.3 | Rac | ||||||||
deltex | DTX1 (human) | WWEx2/RING/DTXc | 12q24.11 | Notch, GRB2, p300 | RANKL | B |
|||||
DTX2 (human) | WWEx2/RING/DTXc | 7p12.3 | |||||||||
DTX3 (human) |
cc/RING/DTXc | 12q13.2 |
|||||||||
DTX4, KIAA0937 (human) | WWEx2/RING/DTXc | 11q12.3 | |||||||||
rhysin 2, BBAP, LOC151636 (human) | RING/DTXc | 3q21.1 | BBAP | BAL, DTX1 | hemato. |
||||||
dactylidin, RNF146, DKFZp434O1427 (human) | RING/WWE | 6q22.1-q22.33 | |||||||||
RWD |
RNF25, AO7(human, mouse) | enhance | RWD/RING | 2q35 | AO7 | p65 | hemato. |
||||
RNF6 (human) | RWD/RING | 13q12.2 | Blimp1 | ||||||||
NY-REN-43, R-LIM, RNF12 (human) | RWD/RING | Xq13-q21 | Ldb1 | estrogen | |||||||
FLJ12270 (human) | WD40/RWD/ZnF(BED)/RING | 16q22.2 | hemato |
||||||||
BMI |
BMI1 (human) |
|
1 | RING/BMI-C | 10p13 | nicotine, Stat4 | transcription repression |
||||
RNF3, DONG1(human) | RING/BMI-C | 4p16.3 | estrogen,
b-catenin |
||||||||
Mel-18, ZNF144 (human) | RING/BMI-C | 17q12 | |||||||||
RNF110 (human) |
RING/BMI-C | 10q23.33 |
|||||||||
MBLR, RNF134 (human) | cc/RING/BMI-C | 19p13.11 | RING1, | ||||||||
NSPC1, MGC10882 (human) |
RING/BMI-C |
2p13.1 |
hemato. |
||||||||
RNF159, MGC16202 (human,
mouse) |
RING/BMI-C | 10q23.33 |
erythroid |
||||||||
NSPc1 (human) | RING/BMI-C | 2p12 | hemato. |
||||||||
RNF110, ZNF144 (human) | RING/BMI-C | 17q12 | |||||||||
UBR1 |
UBR1 (human) | L |
ZnF(UBR1)/RING |
15q13 | RECQL4 |
N-end rule pathway, hemato. |
|||||
UBR2, C6orf133 (human) | 1 |
6p21.1 | |||||||||
KIAA2024 (human) |
cc/RING/ZnF(NFX) |
2q31.1 |
|||||||||
Other | CGR19, CGRRF1 (human, At, Dm) | ?/RING | 14q22.1 | p53 | |||||||
Pirh2, CHIMP, ARNIP, RCHY1 (human, mouse) | ?/RING | 4q21.1 | p53 | PLAG1, AR | p53, irrad. | ||||||
ZNF294, C21orf10 (human) | ?/RING | 21q22.11 | |||||||||
TOPORS,
LUN, TP53BPL (human) |
?/RING/? |
9p21 |
p53 | TopoI, DNA,
AAV2Rep78/68 |
|||||||
ZNRF2, LOC223082 (human) | NIN283/ZnF/RING | 7p15.1 | DC (human) |
||||||||
NIN283, Zrfp1, ZNRF1 (human, mouse) | NIN283/ZnF/RING | 16q23.1 | fetal brain |
||||||||
RNF44, KIAA1100 (human) | KIAA1100-N/RING | 5q35 | hemato. |
||||||||
RNF38 (human) | KIAA1100-N/RING | 9p13-p12 | |||||||||
FLJ20315 (human) | FLJ20315-N/RING/? | 17pter-p13.1 | |||||||||
FLJ12747 (human) | FLJ20315-N/RING/? | 22q12.1 | |||||||||
Mahoganoid,
mahogunin, GP2B, CD41B, ITGA2B, RNF156, KIAA0544,
MGRN1 (human,
mouse, rat, Dm) |
md | KIAA0544/RING | 16p13.13 | hair color | |||||||
RNF157, KIAA1917 (human) | KIAA0544/RING | 17q25.3 | |||||||||
Praja1, PJA1, FLJ11830(human) | Praja-N/RING | Xq12 | Praja1, Dlxin-1 | UbcH5B | |||||||
PJA2, NEURODAP1, KIAA0438 (human) | Praja-N/RING | 5q21.3 | UbcH5B | ||||||||
RNF126, FLJ20552 (human) | RNF126-N/RING | 19p13.3 | hemato. |
||||||||
ZNF364 (human) | RNF126-N/RING | 1q21.1 | erythroid |
||||||||
RNF1, RING1 (human) | RING/RNF1-C | 6p21.3 | SCF | ||||||||
RNF2, DING, BAP-1(human) | RING/RNF1-C | 1p36.13-q31.3 | Hip-2,
S6'
|
||||||||
CCNB1IP1, HEI10 (human) | RING/? | 14q11.1 | cyclins B1, E2 | hemato.,
epithelial |
Subgroup | Protein Name | Apoptosis | NF-kB | KO | Strucuture | Locus | 3D | Substrate | (other or undefined) binding partners | upstream regulators | Memo |
small | ZFP26, RNF141 (human, mouse) | ?/RING | 11pter-p15.4 | ||||||||
RNF4 (human) | RING | 4p16.3 | hemato. |
||||||||
RNF5, Rma1 (human) | RING | 6p21.3 | Paxillin | ||||||||
ROC1 (human) | mediate | RING | 22q13.2 | Skp2, p27CDKI, IkBa,E2F1, cyclin D1, Sic1, Cln1/2, p53, Smad3 | cullins, CAND1, Skp1, Skp2, UBC5c, NEDD8 | SCF E3 | |||||
ROC2, SAG, RNF7 (human) | protect | RING | 3q22-q24 | cullin-4A | |||||||
Rbx1 (human) | RING | 22q13.2 | w/Skp1+2/Cul1 | HIF1a, Vav | Skp1, Skp2, Cul1 | VEGF | VCB-CUL2 E3 | ||||
APC11, ANAPC11 (human) | RING | 17q25.3 | cyclins, Pds1, | H2O2 |
|||||||
RNF11 (human) | PY/RING | 1pter-p22.1 | Smurf2, RNF11, Smad2, Smad3, p73, | Smurf2,
AIP4;
Akt |
CIITA, Blimp1 | ||||||
RNF24 (human) | RING | 20p13-p12.1 | |||||||||
FLJ23360(human) | RING | 16p13.3 | |||||||||
LOC51255 (human) | RING | 2p24.3-p24.1 | |||||||||
RNF111, arkadia, ARK (human) | RING | 15q21 | |||||||||
RNF122, FLJ12526 (human) | RING | 8p11.23 | |||||||||
RNF121, FLJ11099 (human) | RING | 11cen-q12.1 | |||||||||
RNF135, MGC13061 (human) | RING | 17q11.2 | |||||||||
DKFZp761H1710(human) | RING | * | |||||||||
Viral | ICP0, Vmw110 (HSV11, HSVEB, HSV2H) | RING/? | DNA-PK, ICP0, Pml, Sp100, | Cdc34 | |||||||
MIZ (RING-like domain) | PIAS1 (human) | SAP/MIZ | 15q22 | STAT1(-), p53, Sp3, FAK, Axin | SUMO1, UBC9, CSRP2, Gu, AR, DNA | Sp1, Sp2, Sp3 | hemato., SUMO ligase | ||||
PIAS3 (human) | inhibit |
1q21 | TCF4, C/EBPa, Axin, c-Myb | MITF,
Smad3,
Smad4,
Smad7,
p65 |
|||||||
MIZ1, PIASx (human) |
|
1 | SAP/MIZ | 18q21.1 | STAT1, Axin | IRF8 | UVB |
||||
PIASy (human) | 19p13.3 | ||||||||||
RAI17, hZimp10 (human) | MIZ | 10q23.1 | RA |
F box/SOCS box - SCF related
Box | family | name | species | locus | apoptosis | KO | structure | 3D | targets | binding partners | regulators | expression |
memo |
F | LRR_CC | Skp2, p45 | human | 5p13 | L | F/LRRCC | 1 | (P-Ser): p27Kip1, cyclin E, Myc | RA, estrogen | ubiquitous |
|||
FBL2, FBXL2 | human | 3p22.2 | brain |
||||||||||
FBL3A | human | 13q22 | ubiquitous |
||||||||||
FBL4, FBXL4 | human | 6q16.1-q16.3 | ubiquitous |
||||||||||
FBL5, FBXL5 | human | 4p15.33 | APCs |
||||||||||
FBL6, FBXL6 | human | 8q24.3 | ubiquitous |
||||||||||
FBL7, FBXL7 | human | 5p15.1 | ubiquitous |
||||||||||
FBL8, FBXL9 | human | 16q22.1 | ubiquitous |
||||||||||
FBL11, FBXL11 | human | 11q12.2 | ubiquitous |
||||||||||
FBXL12, FLJ20188 | human | 19p13.2 | thymus |
||||||||||
FBXO37, MGC11279 | human | 10q24.32 | ubiquitous |
||||||||||
MGC15482, FBL2
|
human | 17q12 | F/LRRCC | ubiquitous |
|||||||||
PRAME, OIP4 | human | 22q11.22 | F/LRRCC | Opa | IFNa | ubiquitous |
|||||||
SPRY |
FSN1, LOC200933 |
human,
mouse,
rat,
Xl, zebrafish,
fugu,
Dm, Ce |
F/SPRY |
Alk? |
Rpm1,
Skp1,
Cullin |
ubiquitous |
presynaptic
differentiation |
||||||
ARC | FBX4, FBXO4 | human | 5p12 | F/ARF | Skp1 | ubiquitous |
|||||||
Nucleoplasmin | FBX3 | human | 11p12 | F/Nucleoplasmin | ubiquitous |
||||||||
Cyclin | cyclin F, CCNF, FBX1, FBXO1 |
human | 16p13.3 | F/Cyclin x2 | erhyloid, preB, bone marrow |
||||||||
DSL | LOC51725 | human | 3q21.1 | ZF/DSL/F | sk. muscle, heart |
||||||||
RRC | FBX7, FBXO7 | human | 22q12-q13 | UBQ/F | erhyloid | ||||||||
FBX24, FBXO24 | human | 7q22 | F/RRC | testis |
|||||||||
TRP | FBXO9 | human | 6p12.3-p11.2 | TRP/F | Ct, irrad | erhyloid | |||||||
WD40 | dactylin, SHSF3 | human | 10q24 | 1 | F/WD40 | ubiquitous |
|||||||
beta-TrCP, E3RSIkB, FWD1, BTRC, BTRCP, FBW1A, Slimb | human, mouse, X.laevis, Dm | 10q24-q25 | 1 | F/WD40(x7) | P-Ser: IkBa,b,g, b-catenin, CD4(/w Vpu), Period, Timeless | Wnt-3A | ubiquitous |
||||||
betaTrCP2, BTRC2, FBW1B, FBXW1B | human | 5q35.1 | F/WD40 | P-Ser: IkBa | ubiquitous |
||||||||
C17ORF1 | human | 17p12 | F/WD40 | ubiquitous |
|||||||||
FBXW2 | human | 9q34 | F/WD40 | ubiquitous |
|||||||||
FBXW3 | human | 22q11 | F/WD40 | ubiquitous |
|||||||||
CDC4, AGO, SCFFbw7, FBW7, FBXW7 | human | 4q31.23 |
|
1 | F/WD40 | Cycline E, p-c-Jun | estrogen | brain, B, T, NK |
|||||
unknown | FBG2, Fbx6, FBXO6 |
human | 1p36.23-p36.11 | F/? | cytosolic
glycoprotein |
||||||||
FBX2, NFB42, FBXO2 | human | 1p36.21 | F/FBA | cytosolic
glycoprotein, UL9 |
Skp1, Cullin1, Roc1 | brain, spinal cord |
|||||||
FBX30, FBG3 | human | 1p36.21 | F/? | ubiquitous (highest in brain) |
|||||||||
FBG4, FBXO26 |
human | 19q13.2 | F/? | ubiquitous | |||||||||
FBX21, FBXO21 | human | 12q24.21 | F/? | ubiquitous | |||||||||
Fbx22 | human | 15q24.1 | F/? | ubiquitous | |||||||||
Fbx25 | human | 8p23.3 | ubiquitous | ||||||||||
MoKA, FLJ13962 | human | 5q33.1 | F/? | KLF7 |
ubiquitous | ||||||||
FBXO32, atrogin-1 |
human | 8q24.13 | F/? | AdV, FOXOs | ubiquitous | ||||||||
FBXO30 | human | 6q24 | ?/F | ||||||||||
FBXO34, FLJ20725 | human | 14q22.1 | ?/F | erythroid |
|||||||||
FBH1, FBXO18 | human | 10p15.1 | F/helicase | Skp1 | ubiquitous | ||||||||
Tome-1, GRCC8 | human, mouse,rat, | 12p13 | Skp1 | preB, bone marrow |
|||||||||
morgue | Dm |
|
F/UBCc | DIAP1 | |||||||||
SOCS | Socs | Socs1, CIS1, JAB, SSI1 | human, mouse | 16p13.13 | inhibit/promote | L | SH2/SOCS | JAKs, IRS1,2, IR | EloginB/C,
IRAK,TRIM8,
Tec |
EWS/FLI-1, Egr1, Pim, TNFa, RANKL, IL2, IL4, IL6, IL7, IL9, IL10, IL13, IL15, LIF, EPO, IFNa, IFNb, IFNg, CT1, CNTF, G-CSF, GH, PRL, TSH, insulin, SCF, LPS, CD8/28, PMA, STAT6, PPARg1, JunD, TRIF | ubiquitous | suppressor of cytokine signalling-1 | |
(P-Tyr) | Socs2, CIS2, SSI-2 | human, mouse, chick | 12q | L | SH2/SOCS | JAKs, IRS1,2 | AIRE, IL2, IL6, IFNa, CD3, GH, PRL, insulin, CNTF, GR, ribavirin | ubiquitous | STAT induced STAT inhibitor-2 | ||||
Socs3, CIS3, SSI-3 | human, mouse | 17q25.3 | L | SH2/SOCS | JAKs | NF-kB, STAT1, STAT3 (-), TNFa, RANKL, IL1, IL2, IL3, IL6, IL9, IL10, IL11, IL22, LIF, IFNg, OSM, EPO, TPO, G-CSF, CT1, CNTF, leptin, GH, PRL, TSH, EGP, insulin, IGF-II, PDGF, BFGF,TGFb, endostatin, TIMP1, fumagillin, PS, LTA, Bm, Ld, Lm, LLO, Mt, Tg, HHV8, EV71, Tprim, YopP, PGF2a, IKKs, TRIF | ubiquitous | cytokine-inducible SH2-containing protein 3 | |||||
Socs4, CIS4, SSI4, (SOCS7) |
human, mouse | 14q22.2 | SH2/SOCS | ubiquitous | |||||||||
Socs5, CIS6 | human, mouse | 2p21 | 1 |
SH2/SOCS | IL4R | ubiquitous | |||||||
Socs6 | human, mouse | 18q22.2 |
1 | SH2/SOCS | IR | IRS4 | ubiquitous | ||||||
Socs7, NAP4, Nck |
human, mouse | 17q21.1 |
SH2/SOCS | testis |
|||||||||
ASB | ASB1 | human | 2q37 | Ank/SOCS | ubiquitous | ||||||||
ASB2 | human | 14q31-q32 | Ank/SOCS | sk. muscle, heart |
|||||||||
ASB3 | human | 2p16-p14 | Ank/SOCS | CREB | ubiquitous | ||||||||
ASB4 | human | 7q21-q22 | Ank/SOCS | ubiquitous | |||||||||
ASB5 | human | 4q34.1 | Ank/SOCS | ubiquitous | |||||||||
ASB6 | human, mouse | 9q34.13 |
Ank/SOCS | ubiquitous | |||||||||
ASB7 | human, mouse | 15q26.3 |
Ank/SOCS | ubiquitous | |||||||||
ASB8 | human, mouse | 12q13.12 |
Ank/SOCS | ubiquitous | |||||||||
ASB9 | human, mouse | Xp21.3 |
Ank/SOCS | ubiquitous | |||||||||
ASB10 | human | 7q35 | Ank/SOCS | ubiquitous | |||||||||
ASB11 | human | Xp22.31 | Ank/SOCS | ubiquitous | |||||||||
ASB12 | human | Xq11.1 | Ank/SOCS | ubiquitous | |||||||||
ASB13 | human | 10p15.1 | Ank/SOCS | ubiquitous | |||||||||
ASB14 | human | 3p21.1 | Ank/SOCS | ubiquitous | |||||||||
ASB15 | human | 7q31.31 | Ank/SOCS | ubiquitous | |||||||||
ASB16 | human | 17q21.31 | Ank/SOCS | ubiquitous | |||||||||
ASB17 | human | 1p22.3 | Ank/SOCS | ubiquitous | |||||||||
ASB18 | human | 17q21.31 | Ank/SOCS | ubiquitous | |||||||||
NEUZ | Ozz, NEURL2 |
human, mouse, rat, Dm | 20q13.12 | NEUZ/SOCS | b-catenin | thymus |
|||||||
Elongin A | Elongin A, TCEB3 | human | 1p36.1 | TFS2N/SOCS | ubiquitous | ||||||||
Elongin A2, TCEB3L | human | 18q21.1 | TFS2N/SOCS | ubiquitous | |||||||||
Elongin A3, TCEB3L2 | human | 18q12.3 | TFS2N/SOCS | ubiquitous | |||||||||
MUF-1 | MUF1 | human | 1p34.1 | SOCS/LRR | ubiquitous | ||||||||
RAR | Rar, SEC4L, RAB40B | human | 17q25.3 | Rab/SOCS | brain, spinal cord |
||||||||
RAR2A, RAB40A | human | Xq22.1 | Rab/SOCS | ubiquitous | |||||||||
RARL | human | 16p13.3 | Rab/SOCS | ubiquitous | |||||||||
SSB | SSB1, FLJ22393 | human | 1p36.22 | Rab/SOCS | ubiquitous | ||||||||
SSB2, Grcc9 | human | 12p13.32 | Rab/SOCS | ubiquitous | |||||||||
SSB3 | human | 16p13.11 | Rab/SOCS | ubiquitous | |||||||||
SSB4 | human | 3q24 | Rab/SOCS | ubiquitous | |||||||||
Tubby-like | TULP1 | human | 6p21.3 | 1 | Tubby | ubiquitous | |||||||
TULP2 | human | 19q13.1 | testis | ||||||||||
TULP3 | human | 12p13 | 1 | ubiquitous | |||||||||
VHL (Pro-OH) | human, mouse | 3p26-p25 | 1 | VHL |
1 | HIF1a | Cul2, EloginB/C, TRC8, Jade-1, TRC8 | c-Myc, AP1 | ubiquitous | Von Hippel-Lindau syndrome | |||
WSB | WSB1 | human | 17q11.1 | WD40/SOCS | KF1B | ubiquitous | |||||||
WSB2 | human | 12q24.23 |
WD40/SOCS | brain, spinal cord |
E2, ROCK<CUL1<Skp1<Skp2(F)<Kip(P-Ser)
HECT proteins under construction
family | name | species | locus | apoptosis | KO | structure | 3D | targets | binding partner | regulators | expression |
memo |
WW (binds to PPXY motifi) | NEDD4 | human | 15q | C2/WWx4/HECT | 1 | ENaC, N4BP1, N4BP2, N4BP3, N4WBP5, IGF1R, Cbl | Plic2,
annexin
XIII, Grb10,
UBC4,
UbcH5B, UbcH5C, UbcH6, UbcH7, NDFIP1 |
Sgk | ubiquitous | |||
RSP5, NEDD4L, Nedd4-2 | human | 18q21 | C2/WWx4/HECT | ENaC, RNA polII, Lyn, Syk | LMP2A, UbcH6, UbcH7 | Sgk | ubiquitous | |||||
WWP1 | human | 8q21 | Ce | C2/WWx4/HECT | 1 | EGFR | atrophin-1,CBLC | ubiquitous | ||||
WWP2 | human | 16q22.3 | C2/WWx4/HECT | ENaC | atrophin-1 | hemato. | ||||||
NEDL1, KIAA0322 | human | 7p13 | C2/WWx2/HECT | dishevelled1 | ubiquitous | |||||||
SMURF1 | human | 7q21.1-q31.1 | C2/WWx2/HECT | Smad7,
Smad1,5,8,
Smad4,
MEKK2 |
ubiquitous | |||||||
SMURF2 | human | 17q22-q23 | C2/WWx3/HECT | SnoN,
Smad2,
TGFbR,
RNF11 |
Smad7 | ubiquitous | ||||||
Itch, itchy, AIP4, NAPP1 | human | 20q11.22-q11.23 | a18H | C2/WWx4/HECT | Lyn, Syk, Notch, EGFR, endophilin, occludin | atrophin-1, CBLC, p45/NFE2, Numb, LMP2A | ubiquitous | |||||
UBE3A, E6AP | human | 15q11-q13 | ?/HECT | 1 | VCY2, UbcH6, UbcH7 | TRRAP | ubiquitous | |||||
TRIP12 | human | 2q36.1 | WWE/HECT | ubiquitous | ||||||||
HECTD1 | human | 14q12 | ?/HECT | ubiquitous | ||||||||
FLJ20637 | human | 4q21.3 | HECT | ubiquitous | ||||||||
KIAA0317 | human | 14q24.2 | TM?/Filamin/HECT | ubiquitous | ||||||||
EDD, DD5, Hyd | human | 8q22 | UBA/ZnF(UBR)/(polyA)/HECT | TopBP1 | PR, CIB(KIP) | progestin | hemato. |
DNA damage | ||||
FLJ21156 | human | 1p34.1 | HECT | ubiquitous | ||||||||
FLJ20333 | human | 14q12 | RING(PHD)x2/HECT | testis |
||||||||
HUWE1, Ib772, LASU1, UREB1,
HSPC272 |
human |
Xp11.22 |
FH2/DUF913/UBA/WWE/HECT |
histones |
||||||||
C20orf6, bA526K24 | human | 20p12.1 | hemato. |
|||||||||
RCC1 | Ceb1 , HERC5 |
human | 4q22.1-q23 | RCC1/HECT | cycE | TNFa,
IL1b,
LPS |
ubiquitous | |||||
HERC2 | human | 15q13 | RCC1x4/heme/ZnF/RCC1x12/HECT | ubiquitous | ||||||||
HERC3 | human | 4q21 | RCC1x4/HECT | Ub | ubiquitous | |||||||
HERC4, KIAA1593, DKFZP564G092 | human | 10q22.2 | RCC1x2/HECT | ubiquitous | ||||||||
HERC1, p532, p619 | human | 15q22 | RCC1x2/SPRY/WD40x4/RCC1x4/HECT | ARF1, Rab1, Hsp70 | ubiquitous | |||||||
IQ | UBE3C, KIAA0010 | human | 7q36.3 | IQ/HECT | Brn3b | ubiquitous | ||||||
Ank |
HACE1 |
human |
6q21 |
ANKx6/HECT |
HACE1 |
Cullin
family | name | species | apoptosis | locus | KO | structure | regulators | memo | |
Cullin | Cul1, CDC53 | human, Sc | 7q34-q35 | 1 | Cul | CDC34, Skp1, ROC1, CAND1 | |||
Cul2 | human | 10q11.21 | Cul | ||||||
Cul3 | human | 2q37.1 | Cul | BTBs | |||||
Cul4A | human | 13q34 | 1 | Cul | CAND1 | ||||
Cul4B | human | Xq23 | Cul | ||||||
Cul5, VACM1 | human | 11q22-q23 | Cul | Muf1 | Ets1 | ||||
APC2 | human, Sc | 9 | Cul | APC1(BimE), 3(CDC27), 6(CDC16), 7, 8(CDC23) | |||||
CDC5, CDC5L | human | 6p21 | |||||||
CUL7, KIAA0076 | human | 6p21.1 | APC10/Cul | ||||||
PARC, KIAA0708 | human | sensitize | 6p12.3 | APC10/Cul/SPRY/RING(IBR)x2 | p53 |
Skp1
family | name | species | locus | KO | structure | regulators | memo |
Skp1 | Skp1, p19A | human | 5q22-q35.2 | Skp1 | |||
Elongin B, TCEB1 | human | 15q13.3 | Skp1 | ||||
OCP2, TCEB1L | human | 5q31 | Skp1 |
USPs
family | name | species | apoptosis | NF-kB | locus | KO | structure | (Ub)-substrate | other binding partners | regulators | memo | |
USP |
USP1 | human | 1p32.1-p31.3 | UCH | ||||||||
USP2, UBP41 | human | 11q23.3 | ?/UCH | ARNT2, PTH, PGE2,cAMP | ||||||||
USP3 | human | 15q22.3 | ZnF(UBP)/UCH | |||||||||
USP4, UNP | human | 3p21.3 | DUSP/UCH | Rb, p107, p130 | ||||||||
USP5, ISOT | human | 12p13 | UCH/UBAx2 | |||||||||
USP6, TRE2 | human | 17p13 | TBC/UCH | |||||||||
USP7, HAUSP (human) | human |
|
16p13.3 | MATH/UCH | p53 | EBNA1, HSV1 Vmw110, ataxin-1 | UVB | casp | ||||
USP8 | human | 15q15.3 | UCH/UBAx2 | |||||||||
USP50 |
human |
15q21.1 | UCH |
|||||||||
USP9X | human | Xp11.4 | Evr1_Alr/?//UCH/? | |||||||||
USP9Y | human | Yq11.2 | 1 | ?/UCH/? | ||||||||
USP51 |
human |
Xp11.22 |
||||||||||
USP11, UHX1 | human | Xp11.23 | DUSP/UBQ/UCH | RanBPM | ||||||||
USP12 | human | 13q12.2 | UCH | EV71 | ||||||||
USP13 | human | 3q26.2-q26.3 | ZnF(UBP)/UCH/UBAx2 | |||||||||
USP14, TGT | human | 18p11.32 | ax | UBQ/UCH | Hoxd10 | |||||||
USP52, PAN2 |
human |
12q13.2-q13.3 |
UCH/Exonucelase III |
|||||||||
USP15 | human | 12q14 | DUSP/UCH | Hoxd10, AIRE | ||||||||
USP44 |
human |
12q23.1 |
||||||||||
USP16, UBPM | human | 21q22.11 | cc/??/UCH | |||||||||
USP18, UBP43, ISG43 | human | 22q11.21 | ?/UCH | ISG-prot. | IFNb,
Lm, Pg |
|||||||
USP41 |
human |
22q11.21 |
||||||||||
VDU1, USP33 |
human | 1p31.1 | ZnF(UBP)/UCH/DUSPx2 | VHL | ||||||||
USP20, VDU2 | human | 9q34.2 | ZnF(UBP)/UCH/DUSPx2 | VHL | HCV | |||||||
USP21 | human | 1q22 | ?/UCH | NEDD8 | estrogen | |||||||
USP22 | human | 17p11.2 | ZnF(UBP)/UCH/DUSPx2 | |||||||||
USP25 | human | 21q11.2 | UBA/UIM/UCH/? | |||||||||
USP26 | human | Xq26.2 | ?/UCH | |||||||||
USP29 | human | 19q13.43 | ?/UCH | |||||||||
USP31 | human | 1p36.12 | UCH/DUSP/UBQ | |||||||||
USP48 |
human |
1p36.12 | UCH//? | |||||||||
USP32, USP10 | human | 17q23.3 | TBC/UCH | G3BP | ||||||||
USP34 |
human |
2p15 |
UCH | |||||||||
USP35 |
human |
11q13.4 | ||||||||||
CYLD | human |
|
mediate | 16q12.1 | cyld1 | CapGlyx3/UCH | TRAF2 | IKKg,
TRIP |
NF-kB,
TNFa,
Hi, |
|||
USP45 |
human |
6q16.3 | ZnF(UBP)/UCH | |||||||||
USP49, TRFP |
human |
6p21.1 |
||||||||||
DKFZp451O034 | human (partial), mouse | 6q16.2 | ZnF(UBP)/UCH | |||||||||
LOC255608 | human | 4p16.1 | UCH/�H | |||||||||
USP46, FLJ12552 | human | 4q12 | UCH | |||||||||
USP53 |
human |
4q27 |
||||||||||
USP36, FLJ12851 | human | 7p22.2 | UCH/? | |||||||||
USP42 |
human |
7p22.2 | ||||||||||
USP37 |
human |
2q35 |
||||||||||
USP38, HP43 |
human |
4 |
||||||||||
USP39, SAD1 |
human |
2p11.2 |
||||||||||
USP40 |
human |
2q37.1 |
||||||||||
USP47 |
human |
11p15.3 |
UCH/? |
|||||||||
USP54 |
human |
10q22.3 |
Other proteins
Group | Protein | apoptosis | Locus | KO | 3D | regulators | memo |
E1 |
UBE1, A1S9, A1ST, GXP1, A1S9T,
UBE1X (human) |
Xp11.23 |
ARNT2,
RANTES |
||||
UBE1L (human) | 3p21 |
||||||
UBE1C (human) |
3p24.3-p13 |
1 |
for NEDD8 |
||||
FLJ10808 (human) |
4q13.3 |
||||||
APPBP1 (human) |
16q22 |
for NEDD8, binds to UBA3 |
|||||
SAE1, AOS1, SUA1, HSPC140 (human) |
19q13.33 |
for SUMO | |||||
UBA2,SAE2 (human) |
19q12 |
for SUMO |
|||||
UBE1DC1 (human) |
3q22.1 |
RANTES | |||||
APG7L, autophagy 7, GSA7 (human) |
3p25.3-p25.2 |
for APG12L |
|||||
E2 |
UbcH2, UBE2H,
UBC8, UBCH, E2-20K (human) |
7q32 | TNFa | ||||
UbcH5A, E2D1, UBE2D1 (human) | 10q11.2-q21 | FKHR | |||||
UbcH8, RIG-B, UBE2L6 (human) | 11q12 | PMA, IFNa/b, HCV | IGSylation |
||||
UbcH9, UBE2E3 (human) | 2q32.1 | ||||||
NCE2
(human) |
2q37.3 |
||||||
UbcH10, E2C, UBE2C (human) | 20q13.12 | ||||||
Kua-UEV
(human) |
20q13.2 |
||||||
MGC35130
(human) |
1p31.3 |
||||||
HSPC150 (human) | 1q32.1 | ||||||
UBE2Q,
NICE-5 (human) |
1q22 |
||||||
UBE2G, Ubc7 (human) | 17p13.3 | Blimp1 | |||||
UBE2G2 (human) | 21q22.3 | Pax6 | |||||
E2I, Ubc9, UBE2I (human) | 16p13.3 | ||||||
FTS,
Ft1 (human) |
16q12.2 |
binds
to Akt |
|||||
Ubc3B,
CDC34b (human) |
9p13.2 |
||||||
Cdc34, UBE2R1 (human) | 19p13.3 | ||||||
UBE2S, E2-EPF (human) | 19q13.43 | estrogen | |||||
Ubc12,
UBE2M (human) |
19q13.43 | KF1B | |||||
MGC42638
(human) |
Xq21.1 |
||||||
UbcM2
(human) |
Xp22.31 |
||||||
E2A, Rad6, HR6A,UBE2A (human) | Xq24-q25 | 1 |
Ma, GM-CSF | ||||
UbcH5B, Ubc4, UBE2D2 (human) | 5q31.3 | ||||||
E2B, Rad6B, UBE2B (human) | 5q23-q31 | 1 | Subst.P, LPS | ||||
UbcH5C,
UBE2D3 (human) |
4q24 |
ribavirin | |||||
UBE2E1,
UbcH6 (human) |
3p24.2-p24.1 |
||||||
UBE2E2
(human) |
3p24.2 |
||||||
UbcH7,
UBE2L3 (human) |
22q11.21 |
1 | |||||
Ubc13,
UBE2N (human) |
12q22 |
||||||
E2M (human) | 19q13.2 | ||||||
HIP2, LIG, HYPG (human) | 4p14 | ||||||
Ubc6p, CGI-76, NCUBE1, HSPC153, UBE2J1 (human) | 6q16.1 | ||||||
UBE2J2, NCUBE2 (human) | 1p36.33 | ||||||
DDVIT1, UBE2V2, MMS2 (human) | 8q11.21 | ||||||
FLJ13855, HOYS7 (human) | 17q21.32 | ||||||
FLJ12878,
E2-230k (human) |
17q25.1 |
||||||
FLJ11011 (human) | 8q13.3 | ||||||
HBUCE1
(human) |
7p13 |
||||||
LOC92912
(human) |
15q23 |
||||||
for Bruce, see BIRs | |||||||
Ub & related |
UBC (human) | 12q24.3 | A-Myb, B-Myb, Mt, hypoxia | ||||
UBB
(human) |
17p12-p11.2 |
||||||
RPS27A,
CEP80, UBA80, UBCEP1, HUBCEP80 (human) |
2p16 |
||||||
UBA52,
CEP52, RPL40, HUBCEP52 |
19p13.1-p12 |
||||||
NEDD8 (human) | 14q11.2 | ||||||
diubiquitin,
FAT10, UBQ (human) |
6p21.3 |
||||||
ubiquilin 1,UBQLN1, DA41, DSK2, XDRP1, PLIC-1 (human) | 9q22 |
||||||
ubiquilin
2, Dsk2, CHAP1, LIC-2,
N4BP4, PLIC2, UBQLN2 (human) |
Xp11.23-p11 |
TNFa | |||||
ubiquilin
3,UBQLN3 (human) |
11p15 |
||||||
UBL4,
GDX, DXS254E (human) |
Xq28 |
||||||
ANUBL1,
AN1 (human) |
10q11.22 | ||||||
RAD23A
(human) |
19p13.2 |
||||||
RAD23B
(human) |
9q31.2 |
1 |
|||||
FAU,
FAU1, RPS30 (human) |
11q13 | ||||||
BAT3
(human) |
6p21.3 |
||||||
A1U,
UBIN, C1orf6 (human) |
1q21 |
||||||
PRP21,
SAP114, SF3A120, SF3A1 (human) |
22q12.2 |
||||||
BMSC-UbP,
SB132 (human) |
15q23 |
||||||
DC-UbP
(human) |
5q35.2 |
||||||
MGC10067 (human) | 5q33.3 | ||||||
elongin B (human) | 16p12.3 |
||||||
HERPUD1,
SUP, HERP, Mif1 (human) |
16q12.2-q13 |
||||||
UBPH
(human) |
16p12 |
||||||
FLJ11807
(human) |
10q24.2 |
||||||
LOC164153
(human) |
1p13.2 |
||||||
MGC20470
(human) |
11p15.4 |
||||||
FLJ22313
(human) |
7p14.2 |
||||||
C7orf21,
SB144 (human) |
7q36.1 |
||||||
DDI1
(human) |
11 |
||||||
C20orf86
(human) |
20q13.32 |
||||||
DKFZP434N1923
(human) |
8q24.3 |
||||||
MGC3123
(human) |
17q21.31 |
||||||
ISG15,
UCRP, IFI15, G1P2 (human) |
1p36.33 | PU.1,
Ets1,
IRF4,
IRF8,
TNFa,
IFNa,
IFNb,
LPS,
B-DNA,
hsp65,
Ld,
Lm,
Mt,
Tg,
MVA,
VLP |
|||||
RAP36
(human) |
X | IFNa | |||||
OASL , see proteins
for immunity,. For parkin, UHRF2, C20orf18, ICBP90 & USP14, see
above |
|||||||
SUMO, BAGs & FAF, see other
apotosis factors |
|||||||
APG12L | APG12L (human,
mouse,
fugu,
Dm, Ce, Sc, Sp) |
5q21-q22 |
|||||
GABARAP, MM46 (human) |
17p13.2 |
binds to GABA-A R |
|||||
GABARAPL2, GEF2, GEF-2 (human) |
16q22.3-q24.1 |
||||||
MAP1LC3B (human) |
16q24.2 |
||||||
MAP1LC3A (human) |
20cen-q13 |
||||||
TPRx2/cc/U | CHIP, HSPABP2, NY-CO-7, SDCCAG7 (human) | 16p13.12 | TGFb |
||||
IAP associated | DKFZP586F1524 (human) | 17q11.1 | |||||
RBAF600 | RBAF600 (human) | 1p36.13 | ErbB4 | ||||
Mov34 |
Jab1, Mov34, SGN5, COPS5 (human) |
8q13.1 |
COP9 signalosome subunit 5 |
||||
p40, S12, PSMD7 (human) |
16q23-q24 |
26S subunit 7 |
|||||
Pad1, PSMD14 (human) |
2q24.3 |
||||||
STAMBP, AMSH (human) |
2p13.1 |
1 |
binds to Smurf2/RNF11 |
||||
AMSH-LP (human) |
10q23.32 |
||||||
eIF3-p40, eIF3g, EIF3S3 (human) |
8q24.11 |
||||||
C6.1A (human) |
Xq28 |
||||||
FLJ14981 (human) |
19p13.3 | ||||||
KIAA1915 (human) |
1p32.1 |
On-line review
Apoptosis and Ubiquitination by Lee & Peter (Immunol Rev 2003), Zhang et al. (Oncogene. 2004)Other Articles
IkappaB degradation by Karin & Ben-Neriah (Annu Rev Immunol 2000)
PIAS family by Jackson PK (Genes Dev 2001)
Pml & COP1 by Reyes (Trends Biochem Sci 2001)
RING by Joazeiro & Weissman (Cell 2000), Borden (J Mol Biol 2000)
SOCS by Alexander & Hilton (Annu Rev Immunol 2004), by Alexander (Nat Rev Immunol 2002)
Ubiquitin/proteasome by Muratani & Tansey (Nat Rev Mol Cell Biol 2003)
Ubiquitin ligases and the immune response by Liu YV (Annu Rev Immunol. 2004)
Ubiquitination by Pickart (Annu Rev Biochem 2001), Hershko & Ciechanover (Annu Rev Biochem 1998)
The NEDD8 pathway is essential for SCF-beta-TrCP - mediated ubiquitination and processing of the NF-kB precursor p105 (Amir et al., 2002)
Links
Brief introduction for RING domain by T. Pawson Lab
Brief introduction for ubiquitin-proteosome pathway by M Pagano Lab
HOME | All-in-One Seq Analyzer |